IXICO PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other
companies in this sector in the United Kingdom:
sales of £5.79 million [US$8.10 million]
of which 45%
was Diagnostics Segment),
Avacta Group Plc
(£2.74 million [US$3.83 million]
of which 58%
was Animal Health), and
Fusion Antibodies PLC
(£1.91 million [US$2.68 million]
of which 100%
IXICO PLC reported sales of £4.11 million (US$5.76 million)
September of 2017.
increase of 32.1%
versus 2016, when the company's sales were £3.11 million.